Advanced BioMedical Technologies, Inc. ABMT
OTC PK
| 07/31/2021 | 04/30/2021 | ||||
|---|---|---|---|---|---|
| Net Income | 3.17% | 9.82% | |||
| Total Depreciation and Amortization | 137.50% | -15.65% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -97.07% | -59.09% | |||
| Change in Net Operating Assets | -61.17% | -13.79% | |||
| Cash from Operations | -179.88% | 4.97% | |||
| Capital Expenditure | -42.86% | -13.00% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -42.86% | -13.00% | |||
| Total Debt Issued | 203.67% | -10.18% | |||
| Total Debt Repaid | 67.27% | 89.81% | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 11.11% | 36.36% | |||
| Cash from Financing | 186.29% | -5.39% | |||
| Foreign Exchange rate Adjustments | 300.00% | 700.00% | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -73.68% | -196.15% | |||